메뉴 건너뛰기




Volumn 50, Issue SUPPL. 3, 2002, Pages

Cyclooxygenase inhibition: Between the devil and the deep blue sea

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; ETODOLAC; MELOXICAM; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB;

EID: 0036102091     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.50.suppl_3.iii25     Document Type: Conference Paper
Times cited : (62)

References (72)
  • 2
    • 0003319434 scopus 로고
    • Mucosal injury caused by drugs, chemicals and stress
    • Haubrich WS, Schaffner F, Berk JE, eds. Philadelphia: WB Saunders
    • (1994) th edn. , vol.2 , pp. 656-699
    • Hawkey, C.J.1    Hudson, N.2
  • 4
    • 0028327671 scopus 로고
    • Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs
    • (1994) Lancet , vol.343 , pp. 769-772
    • Garcia Rodriguez, L.A.1    Jick, H.2
  • 5
    • 8944227048 scopus 로고    scopus 로고
    • Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis
    • (1996) BMJ , vol.312 , pp. 1563-1566
    • Henry, D.1    Lim, L.-Y.2    Garcia Rodriguez, L.A.3
  • 10
    • 0032476571 scopus 로고    scopus 로고
    • Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus
    • (1998) Am J Med , vol.105
    • Bjorkman, D.1
  • 13
    • 0033428385 scopus 로고    scopus 로고
    • Effects of nonsteroidal anti-inflammatory drugs on renal function: Focus on cyclooxygenase-2-selective inhibition
    • (1999) Am J Med , vol.107
    • Brater, D.C.1
  • 20
    • 0006242136 scopus 로고    scopus 로고
    • GPRD. Data presented to FDA hearings. 8 February 2001
  • 21
    • 0015237292 scopus 로고
    • Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
    • (1971) Nat New Biol , vol.231 , pp. 232-235
    • Vane, J.R.1
  • 30
    • 0001023001 scopus 로고    scopus 로고
    • Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2
    • The International Consensus Meeting on the Mode of Action of COX-2 Inhibition, 5-6 December 1997
    • (1999) Rheumatology , vol.38 , pp. 779-788
    • Brooks, P.1    Emery, P.2    Evans, J.F.3
  • 31
    • 0033594911 scopus 로고    scopus 로고
    • Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
    • published erratum appears in Proc Natl Acad Sci U S A 1999;96:9666
    • (1999) Proc Natl Acad Sci U S A , vol.96 , pp. 7563-7568
    • Warner, T.D.1    Giuliano, F.2    Vojnovic, I.3
  • 36
    • 0033799852 scopus 로고    scopus 로고
    • COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: A double blind crossover study comparing rofecoxib with placebo and indomethacin
    • (2000) Gut , vol.47 , pp. 527-532
    • Sigthorsson, G.1    Crane, R.2    Simon, T.3
  • 38
    • 0032851480 scopus 로고    scopus 로고
    • A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
    • (1999) Gastroenterology , vol.117 , pp. 776-783
    • Laine, L.1    Harper, S.2    Simon, T.3
  • 39
    • 0034121667 scopus 로고    scopus 로고
    • Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial
    • (2000) Arthritis Rheum , vol.43 , pp. 370-377
    • Hawkey, C.1    Laine, L.2    Simon, T.3
  • 42
    • 0034644396 scopus 로고    scopus 로고
    • Gastrointestinal toxicity with celecoxib vs nonsteroidol anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib long-term arthritis safety study
    • (2000) JAMA , vol.284 , pp. 1247-1255
    • Silverstein, F.E.1    Faich, G.2    Goldstein, J.L.3
  • 43
    • 0031680203 scopus 로고    scopus 로고
    • Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor. Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects
    • (1998) Arthritis Rheum , vol.41 , pp. 1591-1602
    • Simon, L.S.1    Lanza, F.L.2    Lipsky, P.E.3
  • 44
    • 0033601089 scopus 로고    scopus 로고
    • Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
    • (1999) JAMA , vol.282 , pp. 1921-1928
    • Simon, L.S.1    Weaver, A.L.2    Graham, D.Y.3
  • 45
    • 0034644396 scopus 로고    scopus 로고
    • Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and reumatoid arthritis: The CLASS study: A randomized controlled trial
    • (2000) JAMA , vol.284 , pp. 1247-1255
    • Silverstein, F.E.1    Faich, G.2    Goldstein, J.L.3
  • 46
    • 0006242137 scopus 로고    scopus 로고
    • Merck. Data presented to FDA Ft
  • 47
    • 0030787414 scopus 로고    scopus 로고
    • Consumption of non-steroidal anti-inflammatory drugs and the development of functianal renal impairment in elderly subjects. Results of a case-control study
    • (1997) Br J Clin Pharmacol , vol.44 , pp. 85-90
    • Henry, D.1    Page, J.2    Whyte, I.3
  • 48
    • 0343184105 scopus 로고    scopus 로고
    • Consumption of NSAIDs and the development of congestive heart failure in elderly patients: An underrecognized public health problem
    • (2000) Arch Intern Med , vol.160 , pp. 777-784
    • Page, J.1    Henry, D.2
  • 55
    • 0035286901 scopus 로고    scopus 로고
    • Cyclooxygenase-1 specific inhibitors and cardiorenal function: A randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients
    • (2001) Am J Ther , vol.8 , pp. 85-95
    • Whelton, A.1    Fort, J.G.2    Puma, J.A.3
  • 59
    • 0029866403 scopus 로고    scopus 로고
    • A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers
    • (1996) Br J Rheumatol , vol.35 , pp. 61-67
    • Patoia, L.1    Santucci, L.2    Furno, P.3
  • 61
    • 0031685519 scopus 로고    scopus 로고
    • Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients
    • International MELISSA study group. Meloxicam large-scale international study safety assessment
    • (1998) Br J Rheumatol , vol.37 , pp. 937-945
    • Hawkey, C.1    Kahan, A.2    Steinbruck, K.3
  • 62
    • 0031696493 scopus 로고    scopus 로고
    • Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: Results of the safety and efficacy large-scale evaluation of COX-inhibiting therapies (SELECT) trial in osteoarthritis
    • (1998) Br J Rheumatol , vol.37 , pp. 946-951
    • Dequeker, J.1    Hawkey, C.2    Kahan, A.3
  • 64
    • 0033919207 scopus 로고    scopus 로고
    • The risk of gastrointestinal bleed, myocardial infarction, and newly diagnosed hypertension in users of meloxicam, diclofenac, naproxen, and piroxicam
    • (2000) Pharmacotherapy , vol.20 , pp. 741-744
    • Jick, S.S.1
  • 67
    • 0021803847 scopus 로고
    • Long-term evaluation of the efficacy and safety of etodolac in the treatment of rheumatoid arthritis
    • (1985) Adv Ther , vol.2 , pp. 82-95
    • Jacob, G.1
  • 69
    • 0027481411 scopus 로고
    • Double-blind comparison of etodolac sustained-release tablets and diclofenac sustained-release tablets in patients with rheumatoid arthritis
    • (1993) Curr Ther Res Clin Exp , vol.53 , pp. 144-153
    • Porzio, F.1
  • 70
    • 0031050476 scopus 로고    scopus 로고
    • Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis
    • Etodolac Study 326, Rheumatoid Arthritis Investigators Group
    • (1997) J Rheumatol Suppl , vol.47 , pp. 10-16
    • Lightfoot, R.1
  • 72
    • 0031049443 scopus 로고    scopus 로고
    • Comparison of etodolac and piroxicam in patients with osteoarthritis of the hip or knee: A prospective, randomised, double-blind, controlled multicentre study
    • (1997) Clin Drug Invest , vol.13 , pp. 66-75
    • Rogind, H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.